Élodie Picarda

927 citations
13 papers · 688 indexed · 1 hit paper · h-index 9
  • Immunology top 5%
    • T-cell and B-cell Immunology 8
    • Immune Cell Function and Interaction 8
    • Immunotherapy and Immune Responses 4
    • Immune cells in cancer 2
  • Oncology top 10%
    • Renal Transplantation Outcomes and Treatments 3
    • Diabetes and associated disorders 1
    • Adenosine and Purinergic Signaling 1
    • Adipokines, Inflammation, and Metabolic Diseases 1

Élodie Picarda

13 papers receiving 683 citations

Hit Papers

Molecular Pathways: Targeting B7-H3 (CD276) for Human Can...4022016202620192022100200300400

Peers

Élodie Picarda
Comparison fields: 5 of 59
  • Immunology 448
  • Oncology 348
  • Transplantation 27
  • Cancer Research 50
  • Genetics 34
Replace Nan Ring with:
Nan Ring United States
Christoph Klauser Austria
Liliana E. Lucca United States
Anna Morabito Italy
Eva Leung United Kingdom
Christian Seitz Germany
Tiffany C. Blair United States
Evgueni Kountikov United States
Mehrdad Mohseni United States
Gaëlle Martin France
Élodie Picarda relative to Nan Ring United States Nan Ring's profile →
Citations per field
00.5×4.5×
Nan Ring · 1×
Citations per year

Countries citing papers authored by Élodie Picarda

Since Specialization
Citations

This map shows the geographic impact of Élodie Picarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élodie Picarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élodie Picarda more than expected).

Fields of papers citing papers by Élodie Picarda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Élodie Picarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élodie Picarda. The network helps show where Élodie Picarda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Élodie Picarda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Élodie Picarda Line = papers co-authored together Élodie Picarda links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20243
2 202220
3 201914
4 20181
5 201737
6
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapybreakdown →
2016402
7 20152
8 201525
9 201595
10 20156
11 201437
12 201113
13 201033

About Élodie Picarda

Élodie Picarda is a scholar working on Transplantation, Immunology and Physiology, having authored 13 papers that have together received 688 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Immune cells in cancer (2 papers), Adenosine and Purinergic Signaling (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Immunology (448 citations), Oncology (348 citations) and Transplantation (27 citations). Élodie Picarda has collaborated with scholars based in France, United States and Australia. Frequent co-authors include Xingxing Zang, Kim C. Ohaegbulam, Carole Guillonneau, Ignacio Anegón, Séverine Bézie, Karine Renaudin, Laurent Tesson, Claire Usal, Emmanuel Mérieau and Karine Bernardeau. Their work appears in journals such as Cell Reports, Journal of Clinical Investigation, Clinical Cancer Research, The Journal of Immunology and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026